Literature DB >> 8093070

Tissue inhibitor of metalloproteinases (TIMP-1) stimulates the secretion of collagenase from human skin fibroblasts.

I M Clark1, L K Powell, T E Cawston.   

Abstract

This study aimed to investigate possible feedback mechanisms in the control of collagenase (matrix metalloproteinase-1) and tissue inhibitor of metalloproteinases (TIMP-1). Procollagenase, active collagenase, TIMP-1 and collagenase-TIMP complex were applied to human skin and synovial fibroblasts for 48 hours, the cells were washed and the resulting collagenase and TIMP-1 secretion was measured over the following 72 hours using ELISAs. Of the additions, only TIMP-1 showed any measurable effect, stimulating collagenase secretion over a range of 1-8 micrograms/ml. Endotoxin contamination was ruled out as an explanation and the active conformation of the TIMP-1 molecule was shown to be necessary.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8093070     DOI: 10.1006/bbrc.1994.2264

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.

Authors:  G Cox; W P Steward; K J O'Byrne
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

2.  Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1.

Authors:  I M Clark; A D Rowan; D R Edwards; T Bech-Hansen; D A Mann; M J Bahr; T E Cawston
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

3.  Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice.

Authors:  Kyoung-Hee Kim; Kristin Burkhart; Peter Chen; Charles W Frevert; Julie Randolph-Habecker; Robert C Hackman; Paul D Soloway; David K Madtes
Journal:  Am J Respir Cell Mol Biol       Date:  2005-06-09       Impact factor: 6.914

4.  Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis.

Authors:  M P Herman; G K Sukhova; W Kisiel; D Foster; M R Kehry; P Libby; U Schönbeck
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 5.  Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.

Authors:  J Thomas Peterson
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

6.  Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor.

Authors:  Inge Tency; Hans Verstraelen; Ivo Kroes; Gabriële Holtappels; Bruno Verhasselt; Mario Vaneechoutte; Rita Verhelst; Marleen Temmerman
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

7.  TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma.

Authors:  D G Powe; J L Brough; G I Carter; E M Bailey; W G Stetler-Stevenson; D R Turner; R E Hewitt
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Effect of orthodontic forces on levels of enzymes in gingival crevicular fluid (GCF): A systematic review.

Authors:  Priyanka Kapoor; Nitika Monga; Om Prakash Kharbanda; Sunil Kapila; Ragini Miglani; Rajeswari Moganty
Journal:  Dental Press J Orthod       Date:  2019-05-20

9.  Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.

Authors:  Z S Zeng; J G Guillem
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

10.  Inflammatory response in maternal serum during preterm labour.

Authors:  I Tency
Journal:  Facts Views Vis Obgyn       Date:  2014
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.